NICE Ltd vs 10X Genomics Inc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while 10X Genomics Inc trades at $47.2 (market cap $5.48B). The key difference: NICE Ltd and 10X Genomics Inc are close in size by market cap, and 10X Genomics Inc is trading nearer its 52-week high, NICE Ltd nearer its low. Which is the better fit depends on your goals.
| NICE | TXG | |
|---|---|---|
Market Cap | $5.91B | $5.48B |
Sector | Technology | Health |
52-Week High | $170.37 | $45.80 |
52-Week Low | $83.15 | $11.34 |
Enterprise Value | $5.69B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →